Organization: ProMetic Life Sciences Inc

ProMetic enters tech transfer deal with Sartorius Stedim

Montreal’s ProMetic Life Sciences Inc has concluded a second technology transfer deal with Sartorius Stedim Biotech, Aubagne France, which further consolidates its technology presence in Asia. The agreement positions Sartorius as a preferred supplier of filtration equipment and consumables to plasma fractionators using ProMetic’s proprietary manufacturing process….

ProMetic and Blue Blood sign manufacturing deal

Montreal’s ProMetic BioTherapeutics Inc has entered a strategic alliance with Taiwan’s Blue Blood Biotech Corp to develop drugs derived from human plasma and utilizing ProMetic’s proprietary manufacturing process. Blue Blood and ProMetic BioTherapeutics, a subsidiary of ProMetic Life Sciences Inc, will share in revenues projected at $50 million annually. Production will initially focus on hyperimmune…

ProMetic strikes Brazilian licensing deal

Montreal’s ProMetic Life Sciences Inc has entered into a technology transfer and licensing agreement with Brazil’s Tecpar for the manufacture of a complex biopharmaceutical product for the South American market. The agreement combines a proprietary manufacturing process licensed from the National Research Council‘s Biotechnology Research Institute and ProMetic’s bioseparation process using Mimetic Legand technology. Prometic…